Tuberous Sclerosis (TSC): The Skin Signs That Help Diagnose This Genetic Condition

What Is Tuberous Sclerosis Complex?

Tuberous sclerosis complex (TSC) is a genetic disorder caused by mutations in either the TSC1 or TSC2 gene. These genes normally act as "brakes" on cell growth. When they don't work properly, benign tumor-like growths called hamartomas develop in multiple organs throughout the body. TSC affects roughly 1 in 6,000 people. About 75% of cases have a parent with TSC (autosomal dominant inheritance), while about 25% are caused by a new mutation — meaning neither parent has the condition.

TSC can look very different from person to person, even within the same family. Some individuals have only mild skin findings and no serious complications; others deal with severe seizures, intellectual disability, and tumors in multiple organs. Early diagnosis — often triggered by a skin finding — allows families and medical teams to monitor and manage complications proactively.

The Skin Signs of Tuberous Sclerosis

Skin changes are present in nearly all people with TSC and are often the first clue to diagnosis. Here are the most important ones:

1. Hypomelanotic Macules (Ash-Leaf Spots)

These are light-colored patches on the skin, often shaped like a leaf or an oval. They're present in about 85–95% of people with TSC and can appear anywhere on the body, especially the trunk and limbs. They may be subtle and difficult to see in children with fair skin. A Wood's lamp (an ultraviolet light used in a darkened room) makes these patches much more visible. Finding 3 or more of these spots is a major diagnostic criterion for TSC.

2. Confetti Skin

Multiple tiny (1–3 mm) white flecks scattered across the skin, especially on the legs and forearms. These look like confetti sprinkled on the skin and may appear during adolescence.

3. Facial Angiofibromas

Small, firm, pink to red bumps on the cheeks, nose, and chin — often mistaken for acne. They usually appear between ages 2 and 5 and are present in about 75% of people with TSC. Unlike acne, they don't form whiteheads or blackheads. They can be cosmetically bothersome, and topical treatments or laser therapy can improve their appearance.

4. Shagreen Patch

A rough, slightly raised, skin-colored to light brown patch with an orange-peel texture, usually found on the lower back. Present in about 50% of TSC patients, it's made up of collagen-rich tissue (collagenoma).

5. Ungual Fibromas (Koenen Tumors)

Flesh-colored growths emerging from under or beside the toenails or fingernails. These typically appear in adolescence or adulthood and can cause nail deformity. Finding one ungual fibroma in a child without a history of trauma is a significant diagnostic clue.

6. Forehead Plaque

A raised, roughened, skin-colored or slightly yellowish plaque on the forehead — another collagenoma. Less common but diagnostically significant.

What Else Does TSC Affect?

TSC is a multisystem condition. The skin findings are the most visible signs, but the internal manifestations determine long-term health:

• Brain (most impactful): Cortical tubers (growths in brain tissue) cause seizures in 75–90% of TSC patients. Seizures often begin in infancy. Developmental delay and autism spectrum disorder are common.
• Heart: Cardiac rhabdomyomas — benign heart tumors — occur in 30–50% of TSC patients, usually detected by fetal ultrasound. Most shrink on their own by childhood, but large ones can cause heart rhythm problems in infancy.
• Kidneys: Angiomyolipomas (benign kidney tumors) develop in the majority of TSC patients over time. They can grow large enough to cause bleeding or kidney damage if not monitored.
• Lungs: Lymphangioleiomyomatosis (LAM) affects the lungs, primarily in adult women with TSC, causing progressive breathing problems.
• Eyes: Retinal hamartomas and other eye abnormalities occur in some patients.

How Is TSC Diagnosed?

Diagnosis is based on clinical criteria — a combination of major and minor features across organ systems. A doctor needs to identify either 2 major features, or 1 major + 2 minor features. The skin findings count as major criteria. Genetic testing that identifies a TSC1 or TSC2 mutation confirms the diagnosis. About 10–15% of people who clinically meet criteria for TSC do not have an identifiable mutation on standard testing — this does not rule out the diagnosis.

Treatment and Management

There's no cure for TSC, but many aspects of the condition are treatable:

• Seizures: Anti-seizure medications; in some cases, seizure surgery or vagal nerve stimulation
• mTOR inhibitors: Drugs like sirolimus (rapamycin) and everolimus target the exact cellular pathway disrupted by TSC1/TSC2 mutations. They've been shown to shrink brain tumors (subependymal giant cell astrocytomas), kidney tumors (angiomyolipomas), and lung disease (LAM)
• Facial angiofibromas: Topical rapamycin (sirolimus) cream has shown real improvement in facial angiofibromas. Laser therapy (ablative CO2 or pulsed dye laser) can also reduce the bumps cosmetically
• Kidney monitoring: Regular imaging with MRI to catch kidney tumors before they cause bleeding
• Developmental support: Early intervention, occupational therapy, and educational support for children with learning differences

When to See a Dermatologist

• Your infant or child has 3 or more light patches on the skin — especially if confirmed with a Wood's lamp
• Pink or red facial bumps (not typical acne) appear in a young child
• You notice growths around or under your child's nails without a history of injury
• A family member has TSC and you want your child evaluated
• Your child has a TSC diagnosis and facial angiofibromas are causing cosmetic or social distress — treatment options are available

Frequently Asked Questions

If my child has white spots on their skin, does that mean they have TSC?

Not necessarily. Many children have 1–2 small light patches that are completely unrelated to TSC. What raises concern is finding 3 or more hypomelanotic macules (especially when confirmed with a Wood's lamp), or finding these spots alongside other TSC features like seizures, facial bumps, or a family history. A dermatologist or geneticist can help determine whether further evaluation is warranted.

Will my child with TSC have intellectual disability?

Not all children with TSC have intellectual disabilities. The severity depends on many factors, particularly how well seizures are controlled and where the brain tumors (tubers) are located. Many people with TSC have normal intelligence. Early seizure treatment is one of the most important factors in protecting cognitive development, which is why early diagnosis matters so much.

Are the skin growths in TSC dangerous?

In most cases, no — the skin findings in TSC are benign (non-cancerous). They can be cosmetically bothersome, particularly the facial angiofibromas. Some skin lesions, like ungual fibromas, may cause nail problems. The internal growths (in kidneys, brain, heart, lungs) are more medically significant and require monitoring.

What kind of specialist team does a child with TSC need?

TSC is best managed by a multidisciplinary team: a dermatologist (skin), neurologist (seizures and brain), nephrologist (kidneys), cardiologist (heart — especially in infancy), pulmonologist (lungs — in older patients), and ophthalmologist (eyes). Many major children's hospitals have dedicated TSC clinics that coordinate all of this care. Genetic counseling is also important for the whole family.

Trusted Resources

• Tuberous Sclerosis Alliance — support, research, and clinical resources
• American Academy of Dermatology (AAD)
• Mayo Clinic: Tuberous Sclerosis

Always consult a board-certified dermatologist and your child's multidisciplinary care team for personalized guidance on tuberous sclerosis management.